Abstract
Thymosin beta 4 (T beta 4), a peptide of 43 amino acids, binds to actin monomers and inhibits filament formation. In preparations of T beta 4 from bovine lung tissue, the peptide is accompanied by a derivative in which the methionine residue in position 6 is replaced by its sulfoxide. T beta 4 sulfoxide inhibits actin polymerization to an extent approximately 20-times less than T beta 4. While an equimolar amount of T beta 4 prevented actin polymerization almost completely, polymerization with the corresponding amount of the sulfoxide proceeded in a manner similar to that of pure actin, except for a slight retardation. We showed that the decrease in the inhibitory activity is reflected by a 20-times lower affinity to actin. Interestingly, under non-polymerizing conditions, the affinity of T beta 4 sulfoxide for actin is as high as that of T beta 4 (approximately 1 microM). In accordance with this, no differences were found between T beta 4 and the sulfoxide in cross-linking experiments with the monomer, where both forms of the peptide yielded similar amounts of a 47-kDa band representing conjugates of actin and beta-thymosin, as proved by Western-blotting analysis. Likewise, both, T beta 4 and the sulfoxide retarded the exchange of G-actin-bound nucleotide to similar extents. Although the sulfoxide is presumably a product of autoxidation, it is attractive to speculate that oxidation of the methionine residue in T beta 4 may represent a regulatory switch for starting filament formation in non-muscle cells.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.